Global Hemophilia A Drugs Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 165

  • Format: PPT, PDF

Global Hemophilia A Drugs Market – Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The global Hemophilia A drugs market size stood at USD 7.2 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Although hemophilia A is a chronic condition, its effects can be greatly reduced with proper treatment and management. The condition can be defined as an inherited bleeding disorder, which causes poor blood clotting and exaggerated bleeding due to ‘clotting factor’ deficiency. Occurrence rate is higher in males than in females. Recombinant coagulation factor concentrate is the most common treatment for hemophilia A. Increased prevalence of the disease has fueled the demand for various hemophilia A treatment modules that are currently available.

Market Drivers

Favourable research and development in the field of biotechnology for clotting factors, increasing medical tourism, and the increasing campaigns and supportive government initiatives for creating awareness about Hemophilia drugs are projected to drive the market growth as this is likely to drive the development of new treatment approach in the global hemophilia market over the forecast years. Availability of limited treatment therapy options and the growing burden on the regulatory bodies towards its treatment results in increasing R&D efforts. In addition, rising awareness campaigns and supportive initiatives plan by the government to commence early screening of neonates, which is expected to boost the requirement of diagnostic tools related to hemophilia A.

1. Global Hemophilia A Drugs Market Overview…………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Global Prevalence of Hemophilia A
B. Growing R&D Investments and Reimbursement Policies
3. Hemophilia A Market Segmentation………………………………………………………….
A. Drug Class
I. Prophylaxsis
II. On Demand Treatment
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
C. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
4. Hemophilia A Disease Major Drugs Market Share…………………………..
A. Market Analysis, Insights and Forecast – By Revenue
B. Drug Market Share by regional analysis
5. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
6. Key Company Profiles…………………………………………………………………..
A. Pfizer overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
C. Shire Company, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
8. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Hemophilia A drug market
B. Future Opportunities
9. Barriers in Future Growth
10. Conclusion


Market Segmentation

By Drug Class

Based on treatment, the hemophilia market is segmented into prophylaxis and on-demand treatment. On-demand held the largest market share in 2019 and prophylaxis was estimated to be the fastest-growing segment over the forecast period. Prophylaxis is a regular infusion of clotting factor concentrates and is generally used in patients suffering from severe hemophilia and is a widely accepted treatment among the patients, leading towards its growth rate. The duration of this treatment depends on the severity of the patients. In addition, prophylaxis treatment is anticipated to reduce productivity loss with better quality of life outcomes

By Disease Indication:

As of 2019, Hemophilia A type segment was valued at USD 7.2 billion and is expected to dominate the segment by 2028 owing to rising prevalence of hemophilia

By Distribution Channel:

Based on distribution channel, the global market can be segmented in hospital pharmacies, retail pharmacies, retail pharmacies, online and others. The hospital pharmacies segment is anticipated to have the dominant share because the dispensations of drugs at these institutions ensure a greater deal of safety and greater guidance regarding the administration of therapeutics. Pharmaceutical companies are working on building public and private partnerships around the globe to expand awareness, diagnosis, and access to treatments

By Region:

In 2019, North America dominated the market and contributed over 44.4% of the revenue share. Rising prevalence coupled with growing inclination towards prophylaxis treatment is predicted to be the preliminary drivers of regional growth. In U.S., people are diagnosed with this disease at a very young age. However, Asia-Pacific is anticipated to witness the fastest growth over the forecast period. Early diagnosis of the diseases in countries including Japan, India, Indonesia, and Malaysia and rising per capita use of therapies for factor VIII and IX deficiency are the vital impact rendering drivers.

Top 5 Major Players

The Hemophilia A drugs market is moderately competitive and consists of several major players. Few of the key players are developing the novel product and technologies to compete with the existing products while others are acquiring and partnering with the other companies trending in the market. Some of the companies which are currently dominating the market are Shire (Baxalta), CSL Behring, Pfizer, Inc., Bayer AG and, BioMarin.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements